Comparing inhaled corticosteroids

Respiratory Care

Volumn 45, Issue 7, 2000, Pages 846-853

  Colice, Gene L ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Anti inflammatory; Asthma; Corticosteroid; Inhaled

Indexed keywords

ANTIINFLAMMATORY AGENT; GLUCOCORTICOID;

AEROSOL; ASTHMA; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; HUMAN; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; PRACTICE GUIDELINE; REVIEW; STANDARD; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, INHALATION; ADMINISTRATION, TOPICAL; AEROSOLS; ANTI-INFLAMMATORY AGENTS; ASTHMA; CLINICAL TRIALS; DRUG DELIVERY SYSTEMS; GLUCOCORTICOIDS; HUMANS; PRACTICE GUIDELINES;

EID: 0034218830     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the diagnosis and management of asthma. Bethesda, 1997; National Institutes of Health, NHLBI, NIH Publication No. 97-4051. Available at www.nhlbi.nih.gov/guidelines/ asthma/asthgdln.htm. Accessed June 6, 2000.
2. Pauwels RA, Lofdahl CG, Laitinen LA, Schouten JP, Postma DS, Pride NB, Ohlsson SV. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 1999;340(25): 1948-1953.
3. Paggiaro PL, Dahle R, Bakran I, Frith L, Hollingworth K, Efthimiou J. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. Lancet 1998;351(9105):773-780.
4. Alberts C, van der Mark TW, Jansen HM. Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study. Dutch Study Group on Pulmonary Sarcoidosis. Eur Respir J 1995; 8(5):682-688.
5. Pietinalho A, Tukiainen P, Haahtela T, Persson T, Selroos O. Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: a double-blind, placebo-controlled multicenter study. Finish Pulmonary Sarcoidosis Study Group. Chest 1999; 116(2):424-431.
6. The British guidelines on asthma management: 1995 review and position statement. The British Thoracic Society. The National Asthma Campaign. The Royal College of Physicians of London in association with the General Practitioner in Asthma Group, the British Association of Accident and Emergency Medicine, the British Paediatric Respiratory Society and the Royal College of Paediatrics and Child Health.Thorax 1997;52 (Suppl 2):S1-S20.
7. Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bai TR, Hegele RG, Hogg JC. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997;100(1):44-51.
8. Carroll N, Elliot J, Morion A, James A. The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis 1993;147(2):405-410.
9. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993;147:697-704.
10. Vignola AM, Chanez P, Campbell AM, Souques F, Lebel B, Enander I, Bousquet J. Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med 1998;157(2):403-409.
11. Busse W, Elias J, Sheppard D, Banks-Schlegel S. Airway remodeling and repair. Am J Respir Crit Care Med 1999;160(3):1035-1042.
12. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids: new developments (review). Am J Respir Crit Care Med 1998;157(3 Pt 3):S1-S53.
13. Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Wells AF, Roche WR, et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992;145(3):669-674.
14. Trigg CJ, Manolitsas ND, Wang J, Calderon MA, McAulay A, Jordan SE, et al. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994;150(1):17-22.
15. Overbeek SE, Kerstjens HAM, Bogaard JM, Mulder PGH, Postma DS. Is delayed introduction of inhaled corticosteroids harmful in patients with obstructive airways disease (asthma and COPD)? The Dutch CNSLD Study Group. Chest 1996;110(1):35-41.
16. Selroos O, Pietinalho A, Lofroos AB, Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 1995; 108(5):1228-1234.
17. Lawrence M, Wolfe J, Webb DR, Chervinsky P, Kellerman D, Schaumberg JP, Shah T. Efficacy of inhaled fluticasone propionate in asthma results from topical and not systemic activity. Am J Respir Crit Care Med 1997;156(3 Pt 1):744-751.
18. Kelly HW. Establishing a therapeutic index for the inhaled corticosteroids. J Allergy Clin Immunol 1998;102(4 Pt 2):S36-S51.
19. Smith CL, Kreutner W. In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids. Arzneimittelforschung 1998;48(9):956-960.
20. Stellato C, Atsuta J, Bickel CA, Schleimer RP. An in vitro comparison of commonly used topical glucocorticoid preparations. J Allergy Clin Immunol 1999;104(3 Pt 1):623-629.
21. Aksoy MO, Li X, Borenstein M, Yi Y, Kelsen SG. Effects of topical corticosteroids on inflammatory mediator-induced eicosanoid release by human airway epithelial cells. J Allergy Clin Immunol 1999; 103(6):1081-1091.
22. Esmailpour N, Hogger P, Rabe KF, Heitmann U, Nakashima M, Rohdewald P. Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo. Eur Respir J 1997;10(7):1496-1499.
23. Hochhaus G, Mollmann H, Derendorf H, Gonzalez-Rothi R. Pharmacokinetic/pharmacodynamic aspects of aerosol therapy using glucocorticoids as a model. J clin Pharmacol 1997;37(10):881-892.
24. Leach CL, Davidson PJ, Boudreau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur Respir J 1998;12(6):1346-1353.
25. Busse WW, Brazinsky S, Jacobson K, Stricker W, Schmitt K, Vanden Burgt J, et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol 1999;104(6): 1215-1222.
26. Harrison LI, Colice GL, Donnell D, Soria I, Dockhorn R. Adrenal effects and pharmacokinetics of CFC-free beclomethasone dipropionate: a 14-day dose-response study. J Pharm Pharmacol 1999;51(3): 263-269.
27. Wales D, Makker H, Kane J, McDowell P, O'Driscoll BR. Systemic bioavailability and potency of high-dose inhaled corticosteroids: a comparison of four inhaler devices and three drugs in healthy adult volunteers. Chest 1999;115(5):1278-1284.